Exploring Combined Use of Continuous Glucose Monitoring and Anti‐Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin
The findings suggest that CGM use could augment the glycaemic benefits of anti-diabetes medications in people with non-insulin treated type 2 diabetes. These results support broader adoption of CGM.
Authors
- Poorva Nemlekar (ORCID: https://orcid.org/0009-0003-7092-5295)
- Katia Hannah (ORCID: https://orcid.org/0000-0003-1027-4059)
- Courtney R. Green (ORCID: https://orcid.org/0000-0002-9279-0649)
- Gregory J. Norman (ORCID: https://orcid.org/0000-0001-7989-9597)
Institutions
- Dexcom (United States) (US)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1002/edm2.70089
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Dexcom